|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Letters to the Editor |
a Cardiac Surgery Unit, University Hospital, University of Messina, Messina, Italy
b Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, Göteborg, Sweden
Received 14 February 2009; accepted 10 March 2009.
* Corresponding author. Address: UOC Cardiochirurgia, Policlinico G Martino, Università di Messina, Viale Gazzi, 98100 Messina, Italy. Tel.: +39 090 2217086; fax: +39 090 2217086. (Email: salvolentini{at}alice.it).
Key Words: Aortic valve replacement Redo surgery Risk score Minimally invasive surgery
We read with interest the paper of Khaladj and co-workers [1]. The authors performed AVR through redo full sternotomy on 39 patients with still patent coronary grafts (30 LIMA grafts). On the basis of their results the authors showed that high risk patients can be operated with lower risk than anticipated by EuroSCORE risk stratification. They conclude that: old fashioned surgical approach should still be considered the gold standard of treatment for high risk AVR.
We would like to analyse two aspects:
We believe that in experienced hands, those risks may be reduced; however, we could further reduce them. For example, the use of a minimal invasive technique in those kind of patients may be of help, in particular an upper J ministernotomy with transversal sternal incision on the third or fourth right intercostals space. During AVR, there is no need to expose the right ventricle, or the left side of the heart near the pulmonary trunk. Therefore with a J sternal incision, just the right side of the chest is split on one side only. This will allow central arterial cannulation and right atrial cannulation. The right ventricle is not exposed, therefore decreasing the risk of adhesions dissection. The patent LIMA will be left undisturbed on the left side of the chest. There is actually no need to isolate and clamp the LIMA during the aortic cross-clamp time. Different types of myocardial protection may be used with this technique, such as a continuous antegrade coronary blood perfusion or other types of cardioplegia on the surgeon preference. Our group has used this particular minimal invasive approach in 18 patients with patent LIMA with good results. This may be another option to further reduce surgical risk.
References
This article has been cited by other articles:
![]() |
N. Khaladj, M. Shrestha, A. Haverich, and C. Hagl Reply to Lentini et al.: Redo-sternotomy and myocardial protection in patients with patent LIMA-grafts Eur. J. Cardiothorac. Surg., June 1, 2009; 35(6): 1114 - 1115. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |